// App-Quantinova.ai

e20534 : Pooled analysis of venous thromboembolism (VTE) from four trials of necitumumab and chemotherapy for stage IV non-small cell lung cancer (NSCLC).

Researchers

Presenter

  • Kelvin Young

Principal Investigators

  • Luis G. Paz-Ares

  • Nick Thatcher

  • David R. Spigel

  • Javad Shahidi

  • Victoria Soldatenkova

  • Gerrit Grau

  • Raffael Kurek

  • Frances A. Shepherd

Medical Centers

  • Princess Margaret Hospital, Toronto, ON, Canada

  • Hospital Doce de Octubre, Madrid, Spain

  • The Christie Hospital, Manchester, United Kingdom

  • Sarah Cannon Research Institute, Nashville, TN

  • Eli Lilly and Company, Bridgewater, NJ

  • European Statistics, Oncology, Lilly Deutschland GmbH, Bad Homburg, Germany

  • Eli Lilly, Frankfurt, Germany

  • Lilly Deutschland GmbH, Pforzheim, Germany

  • Princess Margaret Cancer Center, Toronto, ON, Canada

Locations

  • Canada

  • Spain

  • Germany

  • United Kingdom

  • United States

Companies

  • Eli Lilly and Compan

  • EMB Statistical Solu

  • Lilly Deutschland Gm

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Non Small Cell Lung cancer

  • Venous thrombosis

  • Lung Cancer

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Carboplatin

  • Gemcitabine

  • Necitumumab

  • Paclitaxel

  • Pemetrexed

  • Cisplatin

Outcome

  • N/A

Study Design

  • Randomized

  • Single Arm

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved